ArticleOncotarget2015

The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.

Nicolas Skrypek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.